HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Insights into functional pharmacology of α₁ GABA(A) receptors: how much does partial activation at the benzodiazepine site matter?

AbstractRATIONALE:
Synthesis of ligands inactive or with low activity at α₁ GABA(A) receptors has become the key concept for development of novel, more tolerable benzodiazepine (BZ)-like drugs. WYS8, a remarkably (105 times) α₁-subtype selective partial positive modulator, may serve as a pharmacological tool for refining the role of α₁ GABA(A) receptors in mediation of BZs' effects.
OBJECTIVES:
Here, the effects of WYS8 on GABA-induced currents and on diazepam-induced potentiation of recombinant BZ-sensitive GABA(A) receptors were studied in more detail. In addition, the behavioral profile of WYS8 (0.2, 1, and 10 mg/kg i.p.), on its own and in combination with diazepam, was tested in the spontaneous locomotor activity, elevated plus maze, grip strength, rotarod, and pentylenetetrazole tests.
RESULTS:
WYS8, applied at an in vivo attainable concentration of 100 nM, reduced the stimulation of GABA currents by 1 μM diazepam by 57 % at α₁β₃γ₂, but not at α₂β₃γ₂, α₃β₃γ₂, or α₅β₃γ₂ GABA(A) receptors. The administration of WYS8 alone induced negligible behavioral consequences. When combined with diazepam, WYS8 caused a reduction in sedation, muscle relaxation, and anticonvulsant activity, as compared with this BZ alone, whereas ataxia was preserved, and the anxiolytic effect of 2 mg/kg diazepam was unmasked.
CONCLUSIONS:
Hence, a partial instead of full activation at α₁ GABA(A) receptors did not necessarily result in the attenuation of the effects assumed to be mediated by activation of these receptors, or in the full preservation of the effects mediated by activation of other GABA(A) receptors. Thus, the role of α₁ GABA(A) receptors appears more complex than that proposed by genetic studies.
AuthorsSrđan Joksimović, Zdravko Varagic, Jovana Kovačević, Michael Van Linn, Marija Milić, Sundari Rallapalli, Tamara Timić, Werner Sieghart, James M Cook, Miroslav M Savić
JournalPsychopharmacology (Psychopharmacology (Berl)) Vol. 230 Issue 1 Pg. 113-23 (Nov 2013) ISSN: 1432-2072 [Electronic] Germany
PMID23685860 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • 8-ethynyl-beta-carboline-3-carboxylate-t-butyl ester
  • Anti-Anxiety Agents
  • Anticonvulsants
  • Carbolines
  • Gabra1 protein, rat
  • Receptors, GABA-A
  • Diazepam
Topics
  • Animals
  • Anti-Anxiety Agents (administration & dosage, pharmacology)
  • Anticonvulsants (administration & dosage, pharmacology)
  • Behavior, Animal (drug effects)
  • Carbolines (administration & dosage, pharmacology)
  • Diazepam (administration & dosage, pharmacology)
  • Dose-Response Relationship, Drug
  • Male
  • Maze Learning (drug effects)
  • Motor Activity (drug effects)
  • Rats
  • Rats, Wistar
  • Receptors, GABA-A (drug effects, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: